Iantrek

Iantrek develops minimally invasive surgical technologies for bio-interventional ophthalmic surgery, treating chronic eye diseases such as glaucoma by restoring the eye's natural fluid outflow pathways.

Company Facts

  • Headquarters: United States
  • Type: scaleup
  • Website: https://www.iantrek.com
  • Industries: Medical Devices, Ophthalmology, Health Care

Investors & Owners

  • Trinity Capital Investment

Recent Transactions

  • Trinity Capital provides $30M growth capital to Iantrek